People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Derma Sciences, Inc. | — | Pharmaceuticals | Series B | $29.1M | $988.7M | 2011 |
Barry J. Wolfenson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barry J. Wolfenson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert G Moussa | 1 | 2 |
| C. Richard Stafford, Esq. | 1 | 1 |
| Bruce F. Wesson | 1 | 1 |
| John E. Yetter | 1 | 1 |
| Stephen T. Wills, CPA, MST | 1 | 1 |
| Edward J. Quilty | 1 | 1 |
| James T. O'Brien | 1 | 1 |
| Frederic C. Eigner | 1 | 1 |
| Richard J. Keim | 1 | 1 |
| Srini T. Conjeevaram | 1 | 1 |
| Brett F. Hewlett | 1 | 1 |
| Robert C. Cole | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.